APC, MUTYH mutations varies” />

Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Gastroenterology | Nursing | Oncology | Pathology | Journal

Back to Journal Articles

Varied Mutation Prevalence in Multiple Colorectal Adenomas

Last Updated: July 31, 2012.

 

For patients with multiple colorectal adenomas, prevalence of APC, MUTYH mutations varies

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
For patients with multiple colorectal adenomas there is considerable heterogeneity in the prevalence of pathogenic APC and MUTYH mutations, which varies by adenoma count, according to a study published in the Aug. 1 issue of the Journal of the American Medical Association.

TUESDAY, July 31 (HealthDay News) -- For patients with multiple colorectal adenomas there is considerable heterogeneity in the prevalence of pathogenic APC and MUTYH mutations, which varies by adenoma count, according to a study published in the Aug. 1 issue of the Journal of the American Medical Association.

Shilpa Grover, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues examined the prevalence of pathogenic APC and MUTYH mutations in 8,676 patients with multiple colorectal adenomas. Participants had undergone full gene sequencing and large rearrangement analysis of the APC gene, with targeted sequence analysis for the two most common MUTYH mutations (Y179C and G396D). Full MUTYH gene sequencing was conducted in individuals with either mutation.

The researchers found that 7,225 individuals had colorectal adenomas (1,457 patients had classic polyposis with ≥100 adenomas and 3,253 had attenuated polyposis with 20 to 99 adenomas). The prevalence of pathogenic APC and bilallelic MUTYH mutations was 80 and 2 percent, respectively, for those with 1,000 or more adenomas; 56 and 7 percent, respectively, for those with 100 to 999 adenomas; 10 and 7 percent, respectively, for those with 20 to 99 adenomas; and 5 and 4 percent, respectively, for those with 10 to 19 adenomas. In multivariable analyses, adenoma count correlated strongly with a pathogenic mutation.

"The mutation probabilities reported here may assist clinicians in their decision to recommend genetic evaluation and counsel patients undergoing genetic testing," the authors write.

Several authors disclosed financial ties to diagnostic and health care companies, including Myriad Genetic Laboratories, which forwarded data sets to the independent investigators.

Abstract
Full Text
Editorial

Copyright © 2012 HealthDay. All rights reserved.


Previous: Cataract Surgery Tied to Lower Hip Fracture Risk in Elderly Next: July 2012 Briefing - Allergy

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.